Boulder Nonlinear Systems Receives Continued Funding from FDA to Develop Anti-counterfeiting Measures for Pharmaceutical Tablets

LAFAYETTE, Colorado | September 24, 2014

Boulder Nonlinear Systems (BNS) is pleased to announce that it has just received funding from the FDA to develop a flexible tablet marking process to help fight the growing global problem of drug counterfeiting. The new project, which is being conducted in collaboration with Professor Thomas Dziubla of the Department of Chemical and Materials Engineering at the University of Kentucky, builds on successful proof-of-concept. In the proof-of-concept, Project Director Dr. Jay Stockley and colleagues showed that advanced BNS spatial light modulator (SLM) technology could be used with edible inks and even edible microlens arrays to create markings of varying complexity on an individual drug tablet.

“This project builds on BNS’s expertise with spatial light modulator based imaging engines,” says Dr. Stockley, “A successful prototype will not only provide a new anti-counterfeit tool in the arsenal of pharmaceutical manufacturers, it also places BNS in a position to leverage this current research to address other laser marking applications.”

About Boulder Nonlinear Systems

Boulder Nonlinear Systems (BNS) is a leader in the research and development of non-mechanical beam steering innovations for practical devices and systems used by government, research and commercial applications. Since 1988, BNS and its dedicated team of scientists and engineers have specialized in the control and manipulation of optical energy. For more information visit: